Argument analysis of the ethical claims made by the pharmaceutical industry regarding drug pricing
Bioethics Open Research · 2023
DOI: 10.12688/bioethopenres.17473.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioethics Open Research, 2023. Verfasst von Sarah Kim und 2 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Extreme pharmaceutical prices in the United States, their causes, and their ethical implications have been the subject of extensive research and criticism. What has often been overlooked, however, is that the pharmaceutical industry itself often uses ethics language and concepts when offering explanations for their prices, a framing that has not yet been adequately assessed in the context of industry actions.
Methods
We conducted an argument analysis of publicly available pharmaceutical industry reports and U.S. Congressional testimony to extract commonly occurring claims regarding their pricing.
Results
Starting with the argument that drug research and development are costly, the claims and justifications made in these reports and testimony often invoke common ethical concepts such as benefit, harm, fairness, and autonomy. The arguments and associated rhetoric are, however, often self-contradictory or poorly reflected in the reality of pharmaceutical companies’ actions and experiences in the marketplace.
Conclusions
By delineating companies’ public-facing ethics language and identifying hypocritical discrepancies between industry rhetoric and actions.
Zitieren
APA
Kim, S., Nathanson, P., & Feudtner, C. (2023). Argument analysis of the ethical claims made by the pharmaceutical industry regarding drug pricing. Bioethics Open Research. https://doi.org/10.12688/bioethopenres.17473.1
Vancouver
Kim S, Nathanson P, Feudtner C. Argument analysis of the ethical claims made by the pharmaceutical industry regarding drug pricing. Bioethics Open Research. 2023. doi:10.12688/bioethopenres.17473.1
BibTeX
@article{Kim2023,
author = {Kim, Sarah and Nathanson, Pamela and Feudtner, Chris},
title = {Argument analysis of the ethical claims made by the pharmaceutical industry regarding drug pricing},
journal = {Bioethics Open Research},
year = {2023},
doi = {10.12688/bioethopenres.17473.1}
}
EUVIMED